Status:

COMPLETED

RCT of Adjunctive Curcumin and the Meru Health Program

Lead Sponsor:

Meru Health, Inc.

Conditions:

Depression

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a randomized controlled trial (RCT) to compare the Meru Health Program plus adjunctive curcumin (MHP-CUR) versus Meru Health Program only (MHP-ONLY) for adults with depression. Meru Health is ...

Detailed Description

This is a randomized controlled trial (RCT) to compare the Meru Health Program plus adjunctive curcumin (MHP-CUR) versus Meru Health Program only (MHP-ONLY) for adults with depression. Meru Health is ...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Patient presenting to the Meru Health online clinic
  • Able to read and understand English
  • Own a Smartphone
  • Willing to commit to doing program practices for 10 minutes a day, 6 days a week for 12 weeks
  • PHQ-9 of 10 or higher

Exclusion

  • Lifetime bipolar disorder or a psychotic disorder
  • Possible cognitive impairment
  • Substance use disorder in the past 3 months
  • Active suicidal ideation with at least some intent to act
  • Pregnant, breastfeeding, or desiring to become pregnant in the next 6 months
  • Self-reported current suffering from a major medical illness including neurodegenerative/neuroinflammatory disorders, anemia, Alzheimer's disease, stroke, Parkinson's disease, or multiple sclerosis, autoimmune disorders, diabetes, inflammatory bowel disease, chronic obstructive pulmonary disease, asthma, coagulation disorder, cardiovascular disease, hypertension, chronic fatigue syndrome, fibromyalgia
  • Self-reported current use of glucocorticoids, antibiotics, anticoagulant medications, antioxidant supplements (including curcumin), herbal supplements, or ω3 polyunsaturated fatty acids
  • Self-reported past suffering from an infection or illness over the past month

Key Trial Info

Start Date :

February 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04744545

Start Date

February 1 2021

End Date

December 30 2021

Last Update

July 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Online

Denver, Colorado, United States, 80014